Cargando…
Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain Benefits
Testosterone replacement therapy has been approved in the United States since the 1950s for men with “classical” hypogonadism. These men have specific and well-recognized hypothalamic, pituitary, or testicular conditions leading to deficient or absent endogenous testosterone. A more controversial tr...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142681/ https://www.ncbi.nlm.nih.gov/pubmed/34041509 http://dx.doi.org/10.1089/andro.2020.0018 |